ArticleSystematic reviews2016

Prognostic biomarkers to identify patients destined to develop severe Crohn's disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation.

Steve Halligan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.